<DOC>
	<DOCNO>NCT03037788</DOCNO>
	<brief_summary>The aim study ass safety , tolerability , pharmacokinetics ( PK ) efficacy escalate concentration GPB subject axillary hyperhidrosis .</brief_summary>
	<brief_title>Investigation Ascending Concentrations Glycopyrronium Bromide ( GPB ) Topical Formulation Subjects With Axillary Hyperhidrosis</brief_title>
	<detailed_description />
	<mesh_term>Hyperhidrosis</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<mesh_term>Glycopyrrolate</mesh_term>
	<criteria>Diagnosis moderate severe primary axillary hyperhidrosis whose HDSS score 2 , 3 4 At least 50 mg male 25 mg female spontaneous rest axillary sweat production one axilla measure gravimetrically room temperature/humidity ( 25°C / 2050 % ) period 5 minute . Male female subject age 18 65 year time inform consent body mass index ( BMI ) 1832 kg/m2 . Corrected QT ( QTc ) ≤450 msec , QTc &lt; 480 msec subject bundle branch block . Able comply protocol requirement , include overnight stay , blood sample collection define protocol subject . Willing able provide write informed consent . Known allergy component investigational product . Hypersensitivity glycopyrrolate Secondary hyperhidrosis , example , hyperhidrosis secondary underlying disease include hyperthyroidism , lymphoma malaria , climacteric hyperhidrosis . Previous surgical treatment hyperhidrosis include sympathectomy , surgical debulking sweat gland , subcutaneous tissue curettage ultrasonic surgery . Botulinum toxin treatment prior 9 month . Present history neuromuscular disease . Angle closure glaucoma precipitation ( narrow angle ) . Mycotic , skin infection dermal disorder include infection anticipate application sit either axilla . Significant cardiac arrhythmia tachycardiac atrial fibrillation frequent extrasystole . Subject diabetes mellitus . Subjects ileus , gastrointestinal stenosis , pronounce chronic inflammatory bowel disease , toxic megacolon . Subjects epilepsy . Use antiperspirants contain aluminium chloride deodorant , oral herbal medicine treatment topical treatment hyperhidrosis within 7 day prior study treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Excessive sweating</keyword>
</DOC>